Home › Heart Attack › Virginia
Heart Attack clinical trials in Virginia
4 studies for Heart Attack are looking for participants at sites in Virginia.
Cities in Virginia
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR-Norfolk Great Bridge, Chesapeake
- Nephrology Associates of Northern Virginia Inc, Fairfax
- Peninsula Kidney Associates, Hampton
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Inova Fairfax Hospital, Falls Church
- Virginia Heart, Falls Church
- Carient Heart and Vascular, Manassas
- and 1 more
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Inova Cardiology - Fairfax, Fairfax
- Virginia Heart, Falls Church
- Virginia Heart - Loudoun, Leesburg
- and 6 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Sentara Norfolk General Hospital, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.